|
2012 Journal Article Antagonism of protease-activated receptor 2 protects against experimental colitis.Lohman, Rink-Jan, Cotterell, Adam J., Suen, Jacky, Liu, Ligong, Do, Anh T., Vesey, David A. and Fairlie, David P. (2012). Antagonism of protease-activated receptor 2 protects against experimental colitis.. Journal of Pharmacology and Experimental Therapeutics, 340 (2), 256-265. doi: 10.1124/jpet.111.187062 |
|
2012 Conference Publication Increasing anti-apoptotic nucleolar protein-3 correlates with cancer progression in renal cell carcinomaRajandram, R., Gobe, G., Wang, Z., Vesey, D. A., Johnson, D. W. and Morais, C. (2012). Increasing anti-apoptotic nucleolar protein-3 correlates with cancer progression in renal cell carcinoma. 48th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Auckland, New Zealand, 27 - 29 August 2012. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. |
|
2011 Conference Publication Modulation of cytochrome P450, metallothionein and heme oxygenase-1 by cadmium in primary cultures of human proximal tubule cellsBoonprasert, K., Na-Bangchang, K., Gobe G. C. and Vesey D. A. (2011). Modulation of cytochrome P450, metallothionein and heme oxygenase-1 by cadmium in primary cultures of human proximal tubule cells. 47th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Adealide, Australia, 19-21 September 2011. Richmond, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2011.01490.x |
|
2011 Conference Publication Cadmium Toxicity To Proximal Tubular Epithelium Of The Kidney: Roles Of Inflammation And Mitochondrial DysfunctionCorbier M, Bennett N, Whitbourne L, Roy S, Vesey DA and Gobe G (2011). Cadmium Toxicity To Proximal Tubular Epithelium Of The Kidney: Roles Of Inflammation And Mitochondrial Dysfunction. World Congress of Nephrology, Vancouver BC, Canada, April 8-12. |
|
2010 Journal Article Transport pathways for cadmium in the intestine and kidney proximal tubule: Focus on the interaction with essential metalsVesey, David A. (2010). Transport pathways for cadmium in the intestine and kidney proximal tubule: Focus on the interaction with essential metals. Toxicology Letters, 198 (1), 13-19. doi: 10.1016/j.toxlet.2010.05.004 |
|
2010 Journal Article Erythropoietin protects against acute kidney injury and failureJohnson, David W., Vesey, David A. and Gobe, Glenda C. (2010). Erythropoietin protects against acute kidney injury and failure. The Open Drug Discovery Journal, 2 (SPEC. ISS.1), 8-17. doi: 10.2174/1877381801002010008 |
|
2010 Conference Publication Essential metals and cadmium toxicity in the kidneyVesey, David (2010). Essential metals and cadmium toxicity in the kidney. Thailand Reverse Brain Drain Project International Conference on Cadmium in Food and Human Health, Phitsanulok, Thailand, 15-17 January 2010. Phitsanulok, Thailand: Naresuan University. |
|
2010 Conference Publication Protease-activated receptor-2 and renal carcinogenesisVesey, D., Rajandram, R., Blakeney, J., Suen, J., Johnson, D., Fairlie, D. and Gobe, G. (2010). Protease-activated receptor-2 and renal carcinogenesis. 46th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Perth Convention and Exhibition Centre, Perth, Western Australia, 12-15 September 2010. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2010.01377_1.x |
|
2010 Conference Publication A Novel Protease-Activated Receptor-2 Antagonist Targeting Inflammation and Proliferation in Human Renal Tubular Epithelial CellsVesey David A., Suen, Jacky Yung, Johnson, David W. and Fairlie, David (2010). A Novel Protease-Activated Receptor-2 Antagonist Targeting Inflammation and Proliferation in Human Renal Tubular Epithelial Cells. Kidney Week, American society of Nephrology, Denver Colorado USA, November 16 - 21. Journal of the American Society of Nephrology: |
|
2009 Book Chapter Isolation and primary culture of human proximal tubule cellsVesey, David A., Qi, Weier, Chen, Xingming, Pollock, Carol A. and Johnson, David W. (2009). Isolation and primary culture of human proximal tubule cells. Kidney Research: Experimental Protocols. (pp. 19-24) edited by John M. Walker, T. D. Hewitson and G. J. Becker. Clifton, NJ, U.S.A.: Humana Press. doi: 10.1007/978-1-59745-352-3_2 |
|
2009 Conference Publication Functional significance of TRAF1 knockdown in renal cell carcinoma anti-cancer treatmentGobe, Glenda C., Rajandram, Retnagowri, Vesey, David A., Wang, Zhiqiang, Bennett, Nigel and Johnson, David W. (2009). Functional significance of TRAF1 knockdown in renal cell carcinoma anti-cancer treatment. American Society of Nephrology Renal Week: 42nd Annual Meeting & Scientific Exposition, San Diego, CA, U.S.A., 27 October - 1 November, 2009. Washington , D.C., U.S.A.: American Society of Nephrology. |
|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney diseaseGobe, GC, Vesey, DA, Bennett, NC and Johnson, DW (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology, incorporating the 15th Asian Colloquium in Nephrology and 2nd Asian Forum of CKD Initiative, Kuala Lumpur, Malaysia, 5–8 May 2008. Richmond, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x |
|
2008 Conference Publication Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injuryGobe, G. C., Yamada, M., Vesey, D. A. and Johnson, D. W. (2008). Recombinant human erythropoietin increases vascular expression of nestin and decreases oxidant-induced endothelial injury in models of ischemic acute kidney injury. 11th Asian-Pacific Congress of Nephrology, Kuala Lumpur, Malaysia, 5–8 May 2008. Carlton, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00954.x |
|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney diseaseBennett, N., Colditz, P., Gobe, G. C., Johnson, D., Patel, J. and Vesey, D. A. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not stop progression to chronic kidney disease. 44th Annual Scientific Meeting of the Australian and New Zealand Society of Nephrology, Newcastle, Australia, 6-10 September 2008. HOBOKEN: Australian and New Zealand Society of Nephrology (ANZSN). doi: 10.1111/j.1440-1797.2008.001013.x |
|
2008 Conference Publication Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responsesGobe, Glenda C., Bennett, Nigel, Patel, Jatin, Colditz, Paul, Vesey, David A. and Johnson, David W. (2008). Modulation of vascular nestin and oxidant-induced endothelial injury by human recombinant erythropoietin in models of ischemic acute kidney injuryo-inflammatory and proliferative responses. Renal Week 2008: American Society of Nephrology Annual Meeting, Philadephia, USA, 14 - 19 November, 2008. Washington, D. C., USA: American Society of Nephrology. |
|
2008 Conference Publication Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney diseaseGobe, G. C., Vesey, D. A., Bennett, N. C. and Johnson, D. W. (2008). Recombinant human erythropoietin reduces ischemic acute kidney injury but does not ameliorate progression to chronic kidney disease. 11th Asian Pacific Congress of Nephrology (APCN), Kuala Lumpur, Malaysia, 4-7 May 2008. Carlton, VIC, Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1797.2008.00953.x |
|
2007 Journal Article Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathwayLi, Jun, Vesey, David A., Johnson, David W. and Gobe, Glenda C. (2007). Erythropoietin reduces cisplatin-induced apoptosis in renal carcinoma cells via a PKC dependent pathway. Cancer Biology Therapy, 6 (12), 1944-1950. doi: 10.4161/cbt.6.12.4975 |
|
2007 Journal Article Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activationVesey, David A., Kruger, Wade A., Poronnik, Philip, Gobe, Glenda C. and Johnson, David W. (2007). Proinflammatory and proliferative responses of human proximal tubule cells to PAR-2 activation. American Journal of Physiology: Renal Physiology, 293 (5), F1441-F1449. doi: 10.1152/ajprenal.00088.2007 |
|
2007 Journal Article Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levelsCheung, Catherine W., Taylor, Paul J., Kirkpatrick, Carl M.J., Vesey, David A., Gobe, Glenda C., Winterford, Clay, Nicol, David L. and Johnson, David W. (2007). Therapeutic value of orally administered silibinin in renal cell carcinoma: Manipulation of insulin-like growth factor binding protein-3 levels. BJU International, 100 (2), 438-444. doi: 10.1111/j.1464-410X.2007.07012.x |
|
2007 Journal Article Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapiesYang, Tao, Vesey, David A., Johnson, David W., Wei, Ming Q. and Gobe, Glenda C. (2007). Apoptosis of tubulointerstitial chronic inflammatory cells in progressive renal fibrosis after cancer therapies. Translational Research, 150 (1), 40-50. doi: 10.1016/j.trsl.2007.01.006 |
